Comparative Coverage of Supplementary and Universally Recommended Immunizations in Children at 24 Months of Age
Authors:
- Daniel WeibelDWDaniel Weibel
- Elisabeth DelaporteEDElisabeth Delaporte
- Alain GervaixAGAlain Gervaix
- Ulrich HeiningerUHUlrich Heininger
- 1 March 2012
- journal article
- research article
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 31 (3) , 217-220
Abstract
The introduction of pneumococcal and meningococcal group C conjugate vaccinations as supplementary (a new category in Swiss immunization recommendations) to universally recommended vaccinations in 2006 prompted this study to investigate their acceptance. The study was performed in 24-month-old healthy children born in the Geneva or Basel areas in Switzerland between January and April 2007. After informed consent had been obtained from caregivers (for this particular study in Basel and in general for providing immunization data in Geneva on an ongoing basis), all universally recommended and supplementary vaccinations administered by ≤24 months of age were analyzed for completeness and timeliness according to set definitions. Sample size calculations and standard statistical tests were applied for comparative data analyses. Of 592 children at the age of 12 months, 94% and 73% had received complete diphtheria-tetanus-pertussis component combination and pneumococcal conjugate vaccinations, respectively. At the age of 24 months, coverage rates for complete booster doses were 77% and 70%, respectively. Rates for MMR doses 1 and 2 at 24 months were 92% and 72%, respectively, and the rate for meningococcal conjugate vaccine (single dose) was 62%. On an average, coverage rates were similar in the 2 study regions except those for pneumococcal conjugate and second dose of MMR, which were approximately 10% higher in Geneva. Compliance with supplementary vaccinations was lower than that with universally recommended vaccinations. This can be explained by the recent introduction of supplementary vaccinations or by the public perception that they are less important than universal vaccinations.Keywords
This publication has 6 references indexed in Scilit:
- What Will It Take to Achieve Measles Elimination in the World Health Organization European Region: Progress From 2003-2009 and Essential Accelerated ActionsThe Journal of Infectious Diseases, 2011
- Updated Postlicensure Surveillance of the Meningococcal C Conjugate Vaccine in England and Wales: Effectiveness, Validation of Serological Correlates of Protection, and Modeling Predictions of the Duration of Herd ImmunityClinical and Vaccine Immunology, 2010
- Serious and invasive pediatric pneumococcal disease: epidemiology and vaccine impact in the USAExpert Review of Anti-infective Therapy, 2010
- Reduction in the incidence of invasive pneumococcal disease after general vaccination with 7-valent pneumococcal conjugate vaccine in GermanyVaccine, 2009
- Immunization rates and timely administration in pre-school and school-aged childrenEuropean Journal of Pediatrics, 2005
- Vaccination des enfants de 28 mois à Genève, Suisse: évolution sur six ans, 1995–2000International Journal of Public Health, 2005